Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)
Clinical trial NCT03610646 · COMPLETED
Trial details
- NCT number
- NCT03610646
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-23
- Primary completion
- 2020-11-10
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.